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proliferation in the SV40 large T antigen immortalized MEFs, but this
INTRODUCTION
Formally described by Hanahan and Weinberg [1] , the hallmarks of cancer incorporate fundamental biological features that are acquired during the development of cancers including sustained proliferation, evasion of growth suppression, replicative immortality and initiation of invasion and metastasis. The actin cytoskeleton is a key player in a number of these cellular processes, with distinctive changes in the organisation of the actin cytoskeleton and expression levels of specific actin binding proteins previously shown to be essential to the cancer cell phenotype [2] [3] [4] [5] . Tropomyosin (Tpm), an integral component and stabilizer of actin filaments is involved in the majority of actin cytoskeletal functions [6] . Tpm belongs to a multi-gene family (TPM1-4 genes in mammals) that generates at least 40 coiled-coil proteins through alternative splicing. Tpms form dimers that assemble as a head-to-tail continuous polymer along the major groove of actin filaments. The isoforms display distinct spatial and temporal subcellular localisation and play a key role in actin filament function by regulating the interaction of actin binding proteins and myosin motors with the filaments [6] [7] [8] [9] [10] [11] [12] . The complex array of distinct actin filament networks found in cells is partly due to the existence and co-expression of multiple Tpm isoforms [13] . In this paper we have used the newly developed nomenclature for Tpm isoforms [14] . The key isoforms studied herein, Tpm2.1, Tpm1.4, Tpm1.6, Tpm1.7, Tpm4.2, and Tpm3.1 correspond to the previous nomenclature of Tm1, Tm6, Tm2, Tm3, Tm4 and Tm5NM1. Oncogenically transformed cells, including experimentally transformed cells, primary cells and patient tumor material have been shown to express a specific repertoire of Tpm isoforms that include the low molecular weight (LMW) isoforms Tpm3.1 and Tpm4.2. In contrast, variations or complete loss of the high molecular weight (HMW) Tpm2.1, Tpm1.4, Tpm1.6 and Tpm1.7 have been reported in different cancer cell types [3, [15] [16] [17] [18] . Although re-expression of the HMW Tpms isoforms in transformed cell lines has been conducted, the ability to reverse the transformed phenotype has been found to be Tpm isoform and cell type dependent [19] [20] [21] [22] [23] . Conversely, in vitro siRNA knockdown and in vivo mouse knockouts have shown that the tropomyosin isoform Tpm3.1 plays a vital role in the regulation of cell proliferation in both normal and cancer cells [15, [24] [25] [26] [27] . The Ras/mitogen-activated-protein-kinase (MAPK) pathway has long been recognized as a crucial regulator of normal cellular proliferation and dysregulation of this pathway is common in a variety of cancer types [28] . Mutations in Ras occur in approximately 30% of human cancers resulting in constitutive activation of the Ras/MAPK pathway [29] . Therapeutics directed at the Ras/MAPK pathway and its downstream effector molecules (Raf, MEK, PI3K/mTOR) have proven useful [30] , however, there is a pressing need to identify novel molecular targets within these pathways to address acquired drug resistance that frequently occurs during treatment with Ras/MAPK inhibitors [31] . A critical step in the transmission of signals from the Ras/ MAPK pathway is the activation and subsequent nuclear translocation of the extracellular signalregulated kinase 1/2 (ERK1/2) [32] . Growth factor stimulation leads to dual phosphorylation of ERK1/2 permitting its interaction with the nuclear shuttling protein Importin 7 (Imp7) [33] . A phosphomimetic peptide known to block the ERK1/2-Imp7 interaction has been shown to inhibit the proliferation of cancer cells in vitro and in xenographs models [34] . In this study, we have investigated the potential of primary murine embryonic fibroblasts (MEFs) devoid of Tpm3.1 to escape the oncogenic effects of mutant H-Ras. WT and Tpm3.1 KO MEFs were firstly immortalized by transduction with SV40 large T antigen, then transformed by mutant H-Ras(V12) and assayed for classical features of malignant transformation. We report that the SV40 immortalized MEFs were dependent on the expression of Tpm3.1 for cell proliferation under growth factor restricted conditions and for anchorage independent growth. However, expression of H-Ras overrode the impact of loss of Tpm3.1 such that H-Ras transformed Tpm3.1 KO MEFs were able to proliferate in the absence of growth factors and were capable of anchorage independent growth and tumor formation in mice. A protein-protein interaction assay demonstrated that aberrant cell proliferation detected in the immortalized Tpm3.1 KO MEFs may be due to a disruption of pERK and Imp7 interactions.
MATERIALS AND METHODS

Cell culture
Primary MEFs were isolated and cultured from day 13.5 embryos derived from the Tpm3.1 KO line C57BL/6JArc [B6-Tpm3 tm2(Δ9d)Pgun ] and corresponding control C57BL/6JArc line as previously described [35, 36] . Cells were maintained in Dulbecco's modified Eagle medium (DMEM) with 10% (v/v) foetal bovine serum (FBS) at 37°C, 5% CO 2 . MEFs were subjected to in vitro oncogenic transformation involving retroviral transduction of SV40 largeantigen and Ras-oncogene [37] . Phoenix A packaging cells were transfected with replication defective retroviral vectors, pBABE-Neo SV40 large T cDNA, pBABE-Puro H-Ras(V12) vector and control vectors [38] to establish stable producer cells that were used to transduce early passage MEFs (< 3 passages) as previously described [39] . Culture media from the Phoenix A (SV40 Neoresistant vector) cells was supplemented with 6 μg/ml Polybrene ® (Sigma Aldrich, Sydney, NSW, Australia) and use to infect first passage MEFs. The cells were first transduced with SV40 large-T and subjected to four days of selection in media containing Geneticin (G418), 400 μg/ml, (Invitrogen, California, USA) to generate WT/LT and KO/LT MEFs, and were then transduced with pBABE-Puro H-Ras(V12) with selection in media containing Puromycin (1.5 mg/ml) (Sigma-Aldrich) to generate SV40 large T + H-Ras transformed fibroblasts, WT/LT/Ras and KO/LT/Ras. Experiments were conducted on two independent stocks of MEFs from different mouse litters, designated 1 and 2. Short tandem repeat (STR) genotyping was performed to verify the identity of the non-primary cell lines used in this study.
Immunofluorescence
MEFs were seeded, 1x10 4 , onto glass chamber slides (Nun Lab-Tek II) (Thermo Scientific, Sydney, NSW, Australia), cultured for 24 h, fixed with 4% (w/v) paraformaldehyde/phosphate-buffered saline followed by permeabilization with 0.1% (v/v) TritonX-100. Cells were stained with Tetramethyl Rhodamine IsoThiocyanate (TRITC)-phalloidin (Sigma Aldrich), 1/1000 and DAPI (Invitrogen, Life Technologies, Melb, Vic, Australia). Coverslips were mounted using FluorSaveTM Reagent (Calbiochem, Sydney, NSW, Australia). Cells were imaged with a Zeiss Axioskop 40 FL (Carl Zeiss) using the 40x/0.65NA objective and photographed using a Zeiss AxioCam MRc CCD camera. 
Western blotting
Soft agar colony forming assay
The soft agar colony assay was performed essential as previously described [39] . WT/LT, KO/LT, WT/LT/Ras and KO/LT/Ras MEFs were plated at 2000 cells/35mm dishes in 0.33% agarose (Sea plaque®, Cambrex Bioscience, Rockland, ME, USA), 20% FBS/DMEM. The 0.33% agarose suspension was added to a preformed layer of 0.5% agarose and incubated at 37°C/5% CO 2 for 14 days. Colonies were fixed with the addition of 1% (v/v) glutaraldehyde and colony morphology and number was assessed using an inverted phase contrast microscope. The diameter of each colony was measured using the ProgRes image analysis software (Jenoptik, Thuringia, Germany).
Proximity ligation assay (PLA)
Protein-protein interactions were detected in situ as previously described [26] using the Duolink II detection kit (Onlink Bioscience, Uppsala, Sweden). Briefly, cells were seeded at 1x10 4 0 C overnight and process according to the instructions provided. Red PLA signal dots were visualised using the Zeiss Axioskop 40 FL (Carl Zeiss), photographed using the Zeiss Axio Cam MRc CCD camera and quantitated using Image J.
Tumor assays
All animal experiments were performed in accordance with UNSW Australia Animal Care and Ethics Committee approval and the National Health and Medical Research Council guidelines. WT/LT/Ras and KO/LT/Ras, 5x10 5 cells in 200 μl DMEM were injected subcutaneously into the left flank of 6-week old female BALB/c nude/nude mice. Seven mice were used for each experimental group. Tumor growth was monitor daily and size measured using digital callipers every 2-3 days. Tumor volume was estimated by measuring the length (l) and the width (w) and using the formula, [V = lw 2 /2]. Mice were euthanized before tumor volume reached ~1000 mm 3 .
Histological analysis of tumors
Tumors were fixed in 4% paraformaldehyde, embedded in paraffin and cut into 4 μm-thick sections, then stained with hematoxylin and eosin.
Statistical analysis
Statistical analysis was performed using the two-tailed nonparametric MannWhitney at the 95% confidence interval (GraphPad Prism 5.0; GraphPad, La Jolla, CA, USA). The results are presented with standard error of the mean (SEM) and number of experiments, denoted as n. P values < 0.05 were considered statistically significant.
RESULTS AND DISCUSSION The Tpm3.1 isoform is commonly expressed in various cancer cell types
The tropomyosin isoform expression profile, including Tpm3.1, 4.2, 2.1, 1.4, 1.6 and 1.7, of various cancer cell types (Suppl. Table 1 in Supplementary material at 10.1515/cmble-2015-0037_sm) was evaluated by western blot analysis. Tpm3.1 and Tpm4.2 were found to be expressed in all of the cell lysates tested ( Fig. 1A and B) . In contrast, there was a wider variation in the expression of the HMW Tpm isoforms (Tpm 2.1, 1.4, 1.6, 1.7) in cancer cell lines relative to that seen in MEFs ( Fig. 1A and B) . Notably, the expression of the HMW Tpms was undetectable in 52% of the cell lines analysed. These observations are consistent with previously published data showing the broad expression of the LMW isoforms Tpm3.1 and Tpm4.2 and variations in the expression levels of the HMW isoforms, particularly in neuroblastoma and melanoma cell lines [3, 15, 16] . Moreover, knockout of Tpm3.1 in mice results in partial embryonic lethality and MEFs isolated from these mice showed reduced cell proliferation in vitro contrasting with an increase in proliferation in MEFs isolated from Tpm3.1 overexpressing mice [26] . Furthermore, cell survival studies conducted using siRNA knockdowns showed that Tpm3.1, unlike Tpm4.2, promotes tumor cell growth and survival [15, 24] . Finally, a novel class of an anti-tropomyosin compound directed to Tpm3.1 reduced tumor cell growth in vitro and in vivo in neuroblastoma and melanoma models [15] . Collectively, these data indicates that Tpm3.1 is an integral component of the actin cytoskeleton of tumor cells and is required for the regulation of cell proliferation. Fig. 2A, B , D, E). Likewise, both WT and KO genotypes exhibited a well-organised actin cytoskeleton with prominent stress fibers ( Fig. 2A, B, D, E) . In contrast, the SV40/H-Ras transduced fibroblasts displayed striking morphological alterations compared to the non-transduced or LT cells, which included the appearance of lengthy protrusions ( Fig. 2C and F arrows) , reduced cell surface area and reduced stress fibers. However there was no apparent morphological difference between the WT/LT/Ras and KO/LT/Ras MEFs. These observations are comparable to those previously reported where transformation by oncogenic Ras leads to alterations in the morphology of cells and organisation of the actin cytoskeleton [44, 45] . Examination of protein by western blot confirmed that the expression level of H-Ras was significantly higher in the SV40/H-Ras transduced cells compared to the endogenous levels in the immortalized MEFs (Fig. 2G) . Comparable levels of H-Ras where detected in the WT/LT/Ras and KO/LT/Ras MEFs.
Decrease expression of the high molecular weight Tpm isoforms in SV40/H-Ras transformed MEFs
The tropomyosin isoform expression profile of the SV40 large T and SV40/H-Ras transformed MEFs was investigated by western blot analysis ( Fig. 3A and B) . The level of expression of Tpm3.1 was significantly upregulated in the SV40 transduced WT MEFs (1.3 ± 0.07 fold) whereas a 1.7 ± 0.05 fold increase was seen in the WT/LT/Ras cells, relative to the non-transduced WT MEFs (Fig. 3A and B, P < 0.01). The expression level of Tpm4.2 was unchanged by expressionof SV40 large T except for the SV40/H-Ras transduced KO MEFs cells, where a slight reduction was detected (P = 0.05) (Fig. 3A and B) . As predicted from studies of human fibroblasts, a significant decrease in the MEFs isolated from A ̶ WT and B ̶ Tpm3.1 KO mice were sequentially transduced with SV40 large T agent to generate C ̶ WT1/LT1 and D ̶ KO1/LT1 followed by oncogenic H-Ras E ̶ WT1/LT1/Ras1 and F ̶ KO1/LT1/Ras1. Representative images of cells immunofluorescence stained with phalloidin (red) to visualise the actin cytoskeleton and DAPI (blue) a nuclear stain. G ̶ 10 μg of total cellular protein isolated from the immortalized and transformed WT and Tpm3.1 KO MEFs was analysed by SDS-PAGE followed by western blotting. Shown is a representative blot probed with the H-Ras antibody and Coomassie stained blot as a loading control. Scale bar = 10 μm. Fig. 3 . Downregulation of the high molecular weight Tpms in the SV40/H-Ras transformed MEFs. A ̶ 10 μg of total cellular protein isolated from the primary, LT and LT/Ras WT and Tpm3.1 KO MEFs was analysed by SDS-PAGE followed by western blotting. Shown are representative blots probed with the Tpm antibodies that detect the low molecular weight Tpms (Tpm3.1 and Tpm4.2), the high molecular weight Tpms (Tpm2.1, 1.4, 1.6, 1.7) and α-tubulin (to evaluate protein loading). B ̶ Tpm levels were determined by densitometry and expressed relative to that seen in the primary WT MEFs, set to 1. Data is pooled from 2 independent cell lysates and 3 blots generated per antibody. Data are mean ± SEM *P < 0.05, ** P < 0.01, ****P < 0.0001, Student's T-test.
expression of the HMW Tpms was detected in the WT/LT/Ras and KO/LT/Ras MEFs, relative to the non-transduced cells (Fig. 3A and B) [15, 38] . Despite the observed Ras-induced downregulation of the HMW Tpms, reported in various different cell types and species, the molecular mechanism(s) is still poor understand [16] .
Tpm3.1 KO SV40 immortalized MEFs display reduced proliferation under low serum
The observed consistent expression of Tpm3.1 in various cancer cells types ( Fig. 1 ; [15] ) prompted us to test the hypothesis that Tpm3.1 contributes to the mitogenindependent growth in immortalized and transformed cells by assessing their proliferation in low-serum media. Cells were seeded in serum containing media, allowed to grow for 24 h and counted. A parallel culture of cells was exposed to serum free media for 72 h (96 h time point, Fig. 4A ). In the presence of serum (24 h time point) no significant difference in the proliferation rate between WT/LT and KO/LT cells was detected. However, after growth in low-serum media (96 h time point), there was a 30% reduction in the proliferation of the KO/LT cells relative to the WT/LT cells (Fig. 4A) . SV40/H-Ras transformed fibroblasts were grown and assessed in the same manner. As was the case with the LT cells, after 24 h of growth in full serum there was no difference in the proliferation rate of the WT/LT/Ras and KO/LT/Ras MEFs. However, the absence of Tpm3.1 had no impact on the mitogen independent proliferative capacity of these cells, contrasting with the effect on LT immortalized cells (Fig. 4B) . In vitro clonogenic assays were performed to assess anchorage-independent growth in semi-solid media, another key hallmark of cancer cells. The colony growth of LT immortalized cells in soft-agarose is shown in Figure 4C . Even though the KO/LT MEFs generated colonies, the size of these colonies were significantly smaller than WT/LT colonies (WT1/LT1 and WT2/LT2 colonies 156.2 ± 3.6, 164.4 ± 3.6 μM and KO1/LT1 and KO2/LT2 125.3 ± 2.5, 127.7 ± 1.6 μM diameter of colonies, P < 0.0001, respectively). Conversely, the KO/LT/Ras MEFs formed colonies that were significantly larger than the WT/LT/Ras MEFs (WT1/LT1/Ras1 and WT2/LT2/Ras2 233.4 ± 5.6, 249.3 ± 19 and KO1/LT1/Ras1, and KO2/LT2/Ras2 356.8 ± 13.8, 340.8 ± 13.2 μM, P < 0.01, P < 0.000, respectively) (Fig. 3D) . The observed increase in the size of the KO/LT/Ras colonies is primarily attributed to the loosely-packed cells, as compare to the tightly formed colonies with smooth outlines of the WT/LT/Ras (Fig. 4E) . The observed loosely-packed colonies are suggestive of weak cell-cell interactions leading to the ability of the KO/LT/Ras MEFs to escape the confinements of the colony and disperse. Tpm3.1 has been identified at the apical junctions formed in LLC-PK1 pig kidney epithelial cells and together with myosin II, the cytoskeletal tension generating myosin, in Caco-2 cells, a human epithelial colorectal cancer cell line [46, 47] . Moreover, depletion of Tpm3.1 in Caco-2 cells, leads to a reduction in cell-cell junctional tension [47] . Thus, the aberrant colonies formed by the KO/LT/Ras MEFs could potentially be as a result of reduced junctional tension giving the cells the ability to disperse from the mass of cells within the colony. Collectively, these data show that Tpm3.1 impacts on the ability of the immortalized cells to proliferate in a mitogen independent manner. However, signalling from oncogenic H-Ras overrides this effect in the absence of Tpm3.1.
H-Ras transformation overrides the defect in in vivo proliferation induced by Tpm3.1 knockout
In order to assess tumorigenicity, immunocompromised mice were subcutaneously injected (5 x 10 5 cells, n = 7 mice per genotype) with both lines of the WT/LT/Ras and KO/LT/Ras MEFs. All mice injected with either WT1/LT1/Ras1 and 2 or KO1/LT1/Ras1 and 2 MEFs developed tumors subcutaneously at the site of injection (Fig. 5A) . Measurement of the mean tumor volumes indicated that the tumor growth rates were similar for each of the cell lines, reaching approximately 1000mm 3 between days 18-21, except for the KO2/LT2/Ras2 line which grew significantly faster (Fig. 5B) . On closer examination of the KO2/LT2/Ras2 line it showed that at day 6 tumor volume was already significantly higher compared to the other lines (27 ± 4.5, 19.9 ± 5, 22.5 ± 2.5 and 57.9 ± 4.7 for WT1/LT1/Ras1, KO1/LT1/Ras1, WT2/LT2/Ras2 and KO2/LT2/Ras2, respectively). This could potential be due to more efficient engraftment. Tumor mass at the time of collection was found to be equivalent in all the groups (P values > 0.05, One-way ANOVA with Bonferroni Multiple Comparisons Test) (Fig. 5C ). Histological examination revealed features of aggressive sarcomas, comprising of spindle-shaped tumor cells, aberrant mitosis and anisokaryosis, with no striking differences between WT/LT/Ras and KO/LT/Ras tumors (Fig. 5D, arrows) . Comparable morphologies of SV40 and H-Ras transduced MEFs-derived tumors have previously been documented [48] . Collectively these data show that constitutive and hyperactivation of a mutant form of H-Ras overrides the observed proliferation defect of immortalized MEFs devoid of Tpm3.1.
Compensatory regulation of Tpm isoform expression could provide a potential explanation for the observed formation of tumors derived from Tpm3.1 KO MEFs. We have previously reported the significant increase in the expression of Tpm3.4/3.7 in Tpm3.5/3.8/3.9 knockout mice [49] , whereas a compensatory increase in the expression of Tpm3.4/3.7 was observed in the Tpm3.1 knockout mice [50] . Therefore, at the conclusion of the in vivo tumorigenicity assay, protein was extracted from the tumors and profiled for Tpm isoform expression. Western blot analysis of representative samples from mice with either WT1/LT1/Ras1 or KO1/LT1/Ras1 tumors showed comparable levels of expression of the LMW (Tpm4.1) and the HMW (Tpm2.1, Tpm1.4, Tpm1.6 and Tpm1.7) isoforms in all the tumors examined. Moreover, tumors derived from the Tpm3.1 KO MEFs remained negative for the expression of Tpm3.1 and any other isoforms derived from the Tpm3 gene (Fig. 5E ).
pERK and Imp7 interactions are impaired in the SV40 immortalized MEFs devoid of Tpm3.1. Activation of one of the key signaling pathways known to regulate cell proliferation, the Ras/Raf/MEK pathway, leads to the dual phosphorylation of ERK (ppERK) [33] . These events result in the nuclear translocation of ppERK by its interaction with the nuclear shuttling protein Importin 7 (Imp7) [33] . This cascade of well-defined events is essential for ERK-induced cell cycle regulation [51, 52] . We have recently demonstrated that MEFs lacking Tpm3.1 have a significantly reduced proliferation rate [26] . Further studies have shown that Tpm3.1 interacts with Imp7 and that absence of Tpm3.1 impedes interaction of pERK with Imp7 and reduces the proliferation rate [26] . Consequently, we investigated the possibility that the observed aberrant proliferation of the immortalized KO MEFs (KO/LT) was due to disruption of pERK-Imp7 interactions. We employed the Duolink in situ proximity ligation assay (PLA) to evaluate the interaction of pERK with Imp7 [53] . This assay detects proteins located within a radius of < 40 nm. Serum stimulation resulted in a significant increase in the number of PLA signal dots representing pERK and Imp7 interactions in both the WT1/LT1 and KO1/LT1 MEFs ( Fig. 5A and C) . However, the number of interactions seen in the KO1/LT1 cells following 15 min serum stimulation was significantly less than those seen in the WT1/LT1 MEFs (15.3 ± 0.81 compared to 19.8 ± 0.72, P < 0.0001, respectively) ( Fig. 6A  and C) . In contrast, there was no significant difference in the number of pERK and Imp7 interactions in the WT1 and KO1/LT1/Ras1 MEFs following 15 min of serum stimulation (46.2 ± 2.6 compared to 52.5 ± 3.0, respectively) ( Fig. 6B  and D) . Collectively these data indicate that in the SV40 large T immortalized MEFs, Tpm3.1-containing actin filaments contribute to the regulation of interactions between pERK and Imp7, resulting in the regulation of cell proliferation. However, expression of a mutant form of H-Ras overrides the observed regulation on cell proliferation by Tpm3.1. Fig. 6 . Tpm3.1 is required for efficient interaction of pERK and Imp7 in SV40 large T antigen immortalized MEFs. The Duolink Proximity Ligation Assay (PLA) was performed in situ in order to detect pERK and Imp7 interactions. Serum starved MEFs were stimulated with serum for 0 and 15 min. Representative merge images of the red PLA signal dots (arrow in A) and blue nuclear counterstain (DAPI) are shown. A ̶ WT1/LT1 and KO1/LT1, B ̶ WT1/LT1/Ras1 and KO1/LT1/Ras1, C ̶ , D ̶ The number of pERK and Imp7 interactions were quantitated per cell using Image J. Scale bar = 10 μm. (n = 2), ****P < 0.0001, Student's T-test.
In this study we show that a Tpm isoform that is broadly expressed in a variety of types of cancer cells, Tpm3.1, influences the mitogen-independent growth of SV40 large T antigen immortalized MEFs. Our results suggest that Tpm3.1-containing actin filaments regulate the association between pERK and Imp7 required for the nuclear shuttling of pERK and efficient cell proliferation. A mutant form of H-Ras overrides the partially inhibitory effect on cell proliferation displayed by cells devoid of Tpm3.1 and cell proliferation is proficient in vitro and in vivo. Thus Tpm3.1 acts downstream of the Ras/MAPK signaling pathway.
